BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.570
+0.090 (2.59%)
Feb 5, 2025, 10:54 AM EST - Market open
BioLineRx Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for BioLineRx stock have an average target of 5.50, with a low estimate of 2.00 and a high estimate of 9.00. The average target predicts an increase of 54.06% from the current stock price of 3.57.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 25, 2024.
Analyst Ratings
The average analyst rating for BioLineRx stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $21 → $9 | Strong Buy | Maintains | $21 → $9 | +152.10% | Nov 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +488.24% | Nov 6, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $2 | Strong Buy | Initiates | $2 | -43.98% | Sep 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +488.24% | Jun 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +488.24% | May 29, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.